Trial intelligence / Profile preview

Probiotics vs Activated Charcoal for Uremic Pruritus

NCT06579066Phase 2Not yet recruiting

Sponsor
Ain Shams University
Start
Sep 2024
Primary completion
Feb 2025
Modality
Drug Delivery Systems, Small Molecules, Live Biotherapeutic Products
01

Overview

Phase 2, randomised, open-label trial of Lactobacillus acidophilus + Bifidobacterium infantis + Enterococcus faecium and activated charcoal in uremic pruritus, sponsored by Ain Shams University. Primary endpoint: Indoxyl sulfate at 4 weeks. Planned start Sep 2024; status: not yet recruiting.

02

Drugs

Lactobacillus acidophilus + Bifidobacterium infantis + Enterococcus faeciumactivated charcoal
03

Conditions

uremic pruritus

Beyond the preview

Go deeper on NCT06579066.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06579066.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call